Trueblood Wealth Management LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Trueblood Wealth Management LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,397 shares of the healthcare conglomerate’s stock after selling 58 shares during the quarter. UnitedHealth Group comprises approximately 1.1% of Trueblood Wealth Management LLC’s portfolio, making the stock its 15th largest holding. Trueblood Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,224,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the third quarter valued at $27,000. Global Wealth Strategies & Associates increased its stake in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $37,000. Finally, Quarry LP increased its stake in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH opened at $510.03 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The company’s 50 day simple moving average is $549.37 and its 200 day simple moving average is $563.18. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.